Skip to Main Content

Author Details

Adithya Cattamanchi
University of California Irvine
2002
211
39
PMIDPaper TitleJournal TitlePublished Year
36319573Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses.Value Health2024
37623745Cost-effectiveness of Low-complexity Screening Tests in Community-based Case-finding for Tuberculosis.Clin Infect Dis2024
38050134Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community.Thorax2024
36754560Innovative COVID-19 point-of-care diagnostics suitable for tuberculosis diagnosis: a scoping review protocol.BMJ Open2023
37716363Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.Lancet2023
37592314A user-centred implementation strategy for tuberculosis contact investigation in Uganda: protocol for a stepped-wedge, cluster-randomised trial.BMC Public Health2023
37745521Preferences of people living with HIV for features of tuberculosis preventive treatment regimens - a discrete choice experiment.medRxiv2023
37549128Impact of intensive adherence counseling on viral load suppression and mortality among people living with HIV in Kampala, Uganda: A regression discontinuity design.PLOS Glob Public Health2023
37582066Acceptability and feasibility of digital adherence technologies for drug-susceptible tuberculosis treatment supervision: A meta-analysis of implementation feedback.PLOS Digit Health2023
37645869New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics.medRxiv2023
37390077Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.PLOS Digit Health2023
37252774Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.J Med Internet Res2023
37152209Increase in rifampicin resistance among people previously treated for TB.Public Health Action2023
37286216Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis.Eur Respir Rev2023
37342088Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial.ERJ Open Res2023
37340456mHealth to improve implementation of TB contact investigation: a case study from Uganda.Implement Sci Commun2023
37231600Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda.Int J Tuberc Lung Dis2023
37202025Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data.Lancet Glob Health2023
37461631A user-centred implementation strategy for tuberculosis contact investigation in Uganda: Protocol for a stepped-wedge, cluster-randomised trial.Res Sq2023
36855045Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring.Int J Tuberc Lung Dis2023
36711999Circulating Cell-Free RNA in Blood as a Host Response Biomarker for the Detection of Tuberculosis.medRxiv2023
36669808Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis.Lancet Glob Health2023
34800394Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis.Lancet Infect Dis2022
35442147Perceptions, preferences, and experiences of tuberculosis education and counselling among patients and providers in Kampala, Uganda: A qualitative study.Glob Public Health2022
35764982Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study.BMC Health Serv Res2022
35730395Transaminitis prevalence among HIV-infected adults eligible for tuberculosis preventive therapy.AIDS2022
35400072Theory-Informed Design of a Tailored Strategy for Implementing Household TB Contact Investigation in Uganda.Front Public Health2022
35667781Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda.Value Health2022
35758702Accuracy of Tongue Swab Testing Using Xpert MTB-RIF Ultra for Tuberculosis Diagnosis.J Clin Microbiol2022
35622692Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden Countries.Trop Med Infect Dis2022
35451001The Role of C-Reactive Protein as a Triage Tool for Pulmonary Tuberculosis in Children.J Pediatric Infect Dis Soc2022
35814294Making cough count in tuberculosis care.Commun Med (Lond)2022
35714072Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda.PLoS One2022
36962541Is aggregated surveillance data a reliable method for constructing tuberculosis care cascades? A secondary data analysis from Uganda.PLOS Glob Public Health2022
36447325Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB.Int J Tuberc Lung Dis2022
36157103Engineered Electroactive Solutions for Electrochemical Detection of Tuberculosis-Associated Volatile Organic Biomarkers.IEEE Sens J2022
36346814Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines.PLoS One2022
36216964Metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosis.Sci Rep2022
35101088Addressing health disparities through implementation science-a need to integrate an equity lens from the outset.Implement Sci2022
35109936Readiness to implement on-site molecular testing for tuberculosis in community health centers in Uganda.Implement Sci Commun2022
32160068Implementing pediatric inpatient asthma pathways.J Asthma2021
33826869Is Glycemic Control the Secret to Tuberculosis Control?Am J Respir Crit Care Med2021
33539400Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda.PLoS One2021
33773327Patient Perspectives and Willingness to Accept Incentives for Tuberculosis Diagnostic Evaluation in Uganda.Value Health Reg Issues2021
33658266Impact of T-Cell Xtend on T-SPOT.<i>TB</i> Assay in High-Risk Individuals after Delayed Blood Sample Processing.J Clin Microbiol2021
34914696Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.PLoS Med2021
34580341Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes.Sci Rep2021
34693036Impact of shelter-in-place orders on TB case notifications and mortality in the Philippines during the COVID-19 pandemic.J Clin Tuberc Other Mycobact Dis2021
34416206Validating novel diagnostic assays for tuberculosis in the context of existing tools.Lancet Glob Health2021
34346901Barriers to the Use of Clinical Decision Support for the Evaluation of Pulmonary Embolism: Qualitative Interview Study.JMIR Hum Factors2021
  • 1 - 50 of 211

Recommended Authors

University Teaching Hospital
Career Start Year 2015
Number of shared co-authors 0
Case Western Reserve University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 0
the Infectious Diseases Institute, College of Health Sciences, Makerere University
Career Start Year 2012
Number of shared co-authors 1
State University of Mato Grosso do Sul
Career Start Year 2011
Number of shared co-authors 3
University of Washington
Career Start Year 2011
Number of shared co-authors 2
University College London Hospitals National Health Service Foundation Trust
Career Start Year 2010
Number of shared co-authors 1
Muhimbili University of Health and Allied Sciences
Career Start Year 2009
Number of shared co-authors 1
Bayero University Kano
Career Start Year 2008
Number of shared co-authors 0
Tuberculosis Research Unit, Case Western Reserve University School of Medicine
Career Start Year 2008
Number of shared co-authors 6
Oregon Health and Science University
Career Start Year 2008
Number of shared co-authors 2
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 1
University Clinical Research Center, University of Sciences
Career Start Year 2006
Number of shared co-authors 0
Impact Health LLC
Career Start Year 2005
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 0
University of Minnesota
Career Start Year 2003
Number of shared co-authors 2
School of Public Health, Makerere University
Career Start Year 2003
Number of shared co-authors 4
College of Health Sciences, Makerere University
Career Start Year 2002
Number of shared co-authors 1
University Clinical Research Center, University of Sciences
Career Start Year 2002
Number of shared co-authors 0
The Fenway Institute
Career Start Year 2002
Number of shared co-authors 1
Children's Hospital of Philadelphia
Career Start Year 2001
Number of shared co-authors 1
University of Washington
Career Start Year 1998
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 2
Chest & Allergy clinic, Imperial College Healthcare NHS Trust, St Mary's Hospital
Career Start Year 1996
Number of shared co-authors 0
Oak Crest Institute of Science
Career Start Year 1992
Number of shared co-authors 2
University of Bologna
Career Start Year 1991
Number of shared co-authors 2
Warren Alpert School of Medicine at Brown University
Career Start Year 1990
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 6
Global Health Institute, University of Antwerp
Career Start Year 1982
Number of shared co-authors 2
Brigham and Women's Hospital
Career Start Year 1979
Number of shared co-authors 1

Collaborators

Makerere University.
Co-authored papers 13
University of California san francisco
Co-authored papers 13
University of California San Francisco
Co-authored papers 7
Harvard Medical School
Co-authored papers 3
University of California at San Francisco
Co-authored papers 3
Stanford University
Co-authored papers 2
Co-authored papers 2
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 2
Infectious Disease Institute, Makerere University
Co-authored papers 2
Co-authored papers 2
University of Nebraska Medical Center
Co-authored papers 2
Co-authored papers 2
Non-Communicable Diseases Research Unit, South African Medical Research Council
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
London School of Hygiene & Tropical Medicine
Co-authored papers 1
University of Wisconsin-Madison
Co-authored papers 1
Co-authored papers 1
Institute for Global Health Sciences, University of California san francisco
Co-authored papers 1
University of Pittsburgh School of Medicine
Co-authored papers 1
Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Oregon Health and Science University
Co-authored papers 1
Co-authored papers 1
University of California
Co-authored papers 1
Institute for Healthcare Policy and Innovation, University of Michigan ann arbor
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1